TransMedics Group
(NASDAQ) TMDX
TransMedics Group Financials at a Glance
Market Cap
$2.35B
Revenue (TTM)
$635.89M
Net Income (TTM)
$171.92M
EPS (TTM)
$4.36
P/E Ratio
15.61
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Price
$68.84
Volume
28,771
Open
$67.29
Price
$68.84
Volume
28,771
Open
$67.29
Previous Close
$68.84
Daily Range
$65.68 - $69.09
52-Week Range
$60.10 - $156.00
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Price
$68.84
Volume
28,771
Open
$67.29
Previous Close
$68.84
Daily Range
$65.68 - $69.09
52-Week Range
$60.10 - $156.00
TMDX News
TMDX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TransMedics Group
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
898
CEO
Waleed H. Hassanein, MD
Website
www.transmedics.comHeadquarters
Andover, MA 01810, US
TMDX Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
15%
Net Income Margin
27%
Return on Equity
45%
Return on Capital
7%
Return on Assets
12%
Earnings Yield
6.41%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.35B
Shares Outstanding
34.56M
Volume
28.77K
Avg. Volume
1.29M
Financials (TTM)
Gross Profit
$362.81M
Operating Income
$108.58M
EBITDA
$148.49M
Operating Cash Flow
$192.84M
Capital Expenditure
$59.25M
Free Cash Flow
$133.59M
Cash & ST Invst.
$488.37M
Total Debt
$469.69M
TransMedics Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$173.93M
+21.2%
Gross Profit
$101.16M
+14.7%
Gross Margin
58.16%
N/A
Market Cap
$2.35B
N/A
Market Cap/Employee
$3.23M
N/A
Employees
728
N/A
Net Income
$7.32M
-71.5%
EBITDA
$25.16M
-30.6%
Quarterly Fundamentals
Net Cash
$357.01M
-71.4%
Accounts Receivable
$90.73M
-36.1%
Inventory
$49.89M
+15.0%
Long Term Debt
$800.24M
+55.2%
Short Term Debt
$18.51M
+563.1%
Return on Assets
11.98%
N/A
Return on Invested Capital
7.03%
N/A
Free Cash Flow
$12.12M
+59.4%
Operating Cash Flow
$24.53M
+959.3%